BECTON, DICKINSON AND COMPANY (BDX) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 13.51B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 50.73B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $13.51B | (m) | (m) | $50.73B | (m) |
| 2026-03-31 | (m) | (m) | (m) | $14.71B | (m) | (m) | $50.83B | (m) |
| 2025-12-31 | (m) | (m) | (m) | $16.92B | (m) | (m) | $54.84B | (m) |
| 2025-09-30 | (m) | (m) | (m) | $17.62B | (m) | (m) | $55.33B | (m) |
| 2025-06-30 | (m) | (m) | (m) | $17.53B | (m) | (m) | $54.90B | (m) |
| 2025-03-31 | (m) | (m) | (m) | $17.67B | (m) | (m) | $54.47B | (m) |
| 2024-12-31 | (m) | (m) | (m) | $17.44B | (m) | (m) | $54.66B | (m) |
| 2024-09-30 | (m) | (m) | (m) | $17.94B | (m) | (m) | $57.29B | (m) |
| 2024-06-30 | (m) | (m) | (m) | $18.13B | (m) | (m) | $55.58B | (m) |
| 2024-03-31 | (m) | (m) | (m) | $15.99B | (m) | (m) | $54.16B | (m) |
| 2023-12-31 | (m) | (m) | (m) | $14.09B | (m) | (m) | $52.27B | (m) |
| 2023-09-30 | (m) | (m) | (m) | $14.74B | (m) | (m) | $52.78B | (m) |
| 2023-06-30 | (m) | (m) | (m) | $14.93B | (m) | (m) | $53.02B | (m) |
| 2023-03-31 | (m) | (m) | (m) | $16.01B | (m) | (m) | $54.39B | (m) |
| 2022-12-31 | (m) | (m) | (m) | $14.27B | (m) | (m) | $53.13B | (m) |
| 2022-09-30 | (m) | (m) | (m) | $13.89B | (m) | (m) | $52.93B | (m) |
| 2022-06-30 | (m) | (m) | (m) | $14.68B | (m) | (m) | $53.20B | (m) |
| 2022-03-31 | (m) | (m) | (m) | $17.58B | (m) | (m) | $54.79B | (m) |
| 2021-12-31 | (m) | (m) | (m) | $16.36B | (m) | (m) | $53.36B | (m) |
| 2021-09-30 | (m) | (m) | (m) | $17.11B | (m) | (m) | $53.87B | (m) |
| 2021-06-30 | (m) | (m) | (m) | $15.70B | (m) | (m) | $54.33B | (m) |
| 2021-03-31 | (m) | (m) | (m) | $17.72B | (m) | (m) | $54.92B | (m) |
| 2020-12-31 | (m) | (m) | (m) | $16.08B | (m) | (m) | $54.75B | (m) |
| 2020-09-30 | (m) | (m) | (m) | $17.22B | (m) | (m) | $54.01B | (m) |
| 2020-06-30 | (m) | (m) | (m) | $17.09B | (m) | (m) | $53.96B | (m) |
| 2020-03-31 | (m) | (m) | (m) | $16.81B | (m) | (m) | $53.52B | (m) |
| 2019-12-31 | (m) | (m) | (m) | $16.95B | (m) | (m) | $51.95B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $18.08B | (m) | (m) | $51.77B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $18.02B | (m) | (m) | $52.23B | (m) |
| 2019-03-31 | (m) | (m) | (m) | $17.56B | (m) | (m) | $52.60B | (m) |
| 2018-12-31 | (m) | (m) | (m) | $17.82B | (m) | (m) | $52.93B | (m) |
| 2018-09-30 | (m) | (m) | (m) | $18.89B | (m) | (m) | $53.90B | (m) |
| 2018-06-30 | (m) | (m) | (m) | $20.35B | (m) | (m) | $53.98B | (m) |
| 2018-03-31 | (m) | (m) | (m) | $22.59B | (m) | (m) | $54.57B | (m) |
| 2017-12-31 | (m) | (m) | (m) | $22.09B | (m) | (m) | $55.36B | (m) |
| 2017-09-30 | (m) | (m) | (m) | $18.67B | (m) | (m) | $37.73B | (m) |
| 2017-06-30 | (m) | (m) | (m) | $18.56B | (m) | (m) | $37.17B | (m) |
| 2017-03-31 | (m) | (m) | (m) | $9.08B | (m) | (m) | $24.12B | (m) |
| 2016-12-31 | (m) | (m) | (m) | $9.04B | (m) | (m) | $24.32B | (m) |
| 2016-09-30 | (m) | (m) | (m) | $10.55B | (m) | (m) | $25.59B | (m) |
| 2016-06-30 | (m) | (m) | (m) | $10.56B | (m) | (m) | $26.02B | (m) |
| 2016-03-31 | (m) | (m) | (m) | $10.86B | (m) | (m) | $26.24B | (m) |
| 2015-12-31 | (m) | (m) | (m) | $10.86B | (m) | (m) | $26.05B | (m) |
| 2015-09-30 | (m) | (m) | $752.00M | $11.37B | (m) | (m) | $26.82B | (m) |
| 2015-06-30 | (m) | (m) | (m) | $11.37B | (m) | (m) | $27.08B | (m) |
| 2015-03-31 | (m) | (m) | (m) | $12.13B | (m) | (m) | $28.29B | (m) |
| 2014-12-31 | (m) | (m) | (m) | $9.94B | (m) | (m) | $18.50B | (m) |
| 2014-09-30 | (m) | (m) | (m) | $3.77B | (m) | (m) | $12.45B | (m) |
| 2013-09-30 | (m) | (m) | (m) | $3.76B | (m) | (m) | $12.15B | (m) |
| 2012-09-30 | (m) | (m) | $202.40M | $3.76B | (m) | (m) | $11.36B | (m) |
| 2011-09-30 | (m) | (m) | $22.00K | $2.48B | (m) | (m) | $10.43B | (m) |
| 2010-09-30 | (m) | (m) | $31.00K | $1.50B | (m) | (m) | $9.65B | (m) |
| 2009-09-30 | (m) | (m) | $200.09M | $1.49B | (m) | (m) | $9.30B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |